Children contraindication

Use in children - Contraindicated in children younger than 2 years of age because of the potential for fatal respiratory depression. The extrapyramidal symptoms that can occur secondary to promethazine administration may be confused with the CNS signs of undiagnosed primary disease (eg, encephalopathy, Reye syndrome). Avoid use in children whose signs and symptoms may suggest Reye syndrome or other hepatic diseases. TRIPROLIDINE HYDROCHLORIDE ... 

Children Contraindicated in children under 2 years of age. Safety and efficacy in children below the age of 12 have not been established. 

Initiate GH replacement therapy based on patient preference. Make sure that the child does not have any contraindications to GH therapy. 

This schedule indicates the recommended ages for routine administration of currently licensed childhood vaccines, as of December 1, 2006, for children aged 7-18 years, Additional information is available at http //www.cdc.gov/nip/recs/child-schedule.htm Any dose not administered at the recommended age should be administered at any subsequent visit, when indicated and feasible. Additional vaccines may be licensed and recommended during the year. Licensed combination vaccines may be used whenever any components of the combination are indicated and other components of the vaccine are not contraindicated and if approved by the Food... 

Dose adjustment in hepatic Impairment The recommended dose of abacavir in patients with mild hepatic impairment (Child-Pugh score 5 to 6) is 200 mg twice daily. To enable dose reduction, use abacavir oral solution (10 ml twice daily) to treat these patients. The safety, efficacy, and pharmacokinetic properties of abacavir have not been established in patients with moderate to severe hepatic impairment therefore, abacavir is contraindicated in these patients. 

Clinicians should be aware that many of their patients may be taking alternative treatments either via self-care or prescribed by CAM practitioners. Inquiring about this should be routine because of potential side effects and drug interactions. A working knowledge of CAM treatments will allow child psychiatrists to give parents and patients advice about safety and effectiveness. Use of St. John s wort in children with unipolar depression may at times be appropriate, particularly in cases where more standard treatments are contraindicated or have failed. However, it should be used cautiously and with an appropriate explanation of its risks and benefits, as a competent clinician would do for any treatment. Use of St. John s wort for other conditions is not currently recommended given the lack of evidence for efficacy. Kava extracts may be used for anxiety, with similar provisos. There are much fewer data about the efficacy and safety of other dietary supplements and their use cannot be supported at this point. 

The meaning of the psychiatric illness to the child and his or her family should be considered. Denial and confusion about the illness may not be expressed directly. Specific points for medication education include (J) the reasons for medications being used, (2) the goals of medication and when they might be achieved (3) the common side effects and when they will emerge (4) the rare side effects and when they might emerge (5) the activities, foods, drinks, and other medications that are contraindicated or require caution (6) recommended parental response to potential side effects and (7) duration of treatment (Kutcher, 1997). 

An urgent meeting of the Group was convened on 4 June 2003 to consider clinical trial data which had just been received by the MHRA on the safety of paroxetine in the treatment of major depressive disorder in children and adolescents. Child and adolescent psychiatrists were invited to join the Group as visiting experts for the discussion of the data. The advice of the group informed CSM s announcement on 10 June, that paroxetine was contraindicated in patients under the age of 18 with major depressive disorder. 

Child-Pugh B) Renal 3 > Contraindicated in patients with active liver disease or with unexplained persistent elevations of serum transaminases Mild to moderate renal insufficiency no... 

Gastric lavage would not be contraindicated for a 3-year-old child who ate a bottle of unknown tablets. 

Treatment in both children involved the use of allopurinol - but at a lesser dosage (5 mg/kg/2hh) because of the retention of the principal metabolite oxipurinol in severe renal failure Careftil monitoring of plasma oxipurinol levels is desirable For the HGPRT deficient child alkali was also given to enhance uric acid solubility It was not prescribed in the APRT deficient child since 2 8-dihyroxy adenine solubility is unaffected by alkali and its use may even be contraindicated ... 

Relative contraindications include unacceptable medical risk for isolation, unmanageable coagulation disturbance, severe reparative dysfunction, acute or severe chronic renal failure (creatinine clearance below 30 ml/min), liver cirrhosis greater than Child B, leukocytes below 1500 GPT/1, thrombocytes below 50,000 GPT/1. 

Fig. 10.2. Antero-posterior, digital subtraction angiogram of the abdomen of a patient with unresectahle HCC showing clot in portal veins. This arterial phase hepatic angiogram shows early arterial-portal venous shunting through a hypervascu-lar tumor (white arrow). The shunting into the portal veins uncovered a filling defect (clot) in the main (black arrowhead) and left (white arrowhead) portal veins. Embolization with 1 cc of Gelfoam slurry shut down the shunt while the tumor supply was preserved. This allowed us to proceed with TACE. The presence of portal vein thrombosis should not be considered by itself as a contraindication to TACE. Unpublished data from our institution shows TACE to be a safe and effective procedure in Child-Pugh A and B patients...

Partial nephrectomy is sometimes considered in unilateral WT when the child has contralateral non-functioning kidney or associated renal disease or associated predisposing syndrome (SIOP 2001). Nevertheless, partial nephrectomy is contraindicated in unilateral multifocal tumors, central location, involvement of more than 1/3 of kidney, preoperative tumor rupture or biopsy, infiltration of extra-renal structures, intra-abdominal metastases or lymph nodes, thrombosis of RV or I VC, involvement of calyces or hematuria (SIOP 2001). 

Contraindications to percutaneous nephrolithotomy are infrequent, but include a child with an uncorrectable coagulopathy. Children with a small renal pelvis cause technical problems. Renal access maybe difficult, and there maybe insufficient room to maneuver instruments if the collecting system is not large enough. Also, in small children, the size of the kidneys may make dilation to greater than 10-12 French dangerous for fear of a renal fracture. 

---